Related Experiment Video
Updated: Oct 17, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
FOLFOX-Associated Ventricular Fibrillation Arrest in a Patient With Colon Cancer
Soad Al Osta1, Marwan Ahmed1, Weining David Xu2
1Department of Medicine, MedStar Health Georgetown University, Baltimore, Maryland, USA.
Background:
Fluoropyrimidine cardiotoxicity is uncommon but may cause life-threatening ventricular arrhythmias.
Case Summary:
A 43-year-old man with stage IIIB colon cancer developed chest discomfort and out-of-hospital ventricular fibrillation arrest approximately 72 hours after his first folinic acid (leucovorin), fluorouracil (5-FU), and oxaliplatin (FOLFOX) cycle. Electrocardiography showed anterior ST-segment elevations, but coronary angiography demonstrated nonobstructive left and right coronary arteries. Echocardiography showed a left ventricular ejection fraction of 25% to 30%, which improved to approximately 50% on cardiac magnetic resonance imaging without myocardial edema or late gadolinium enhancement. FOLFOX was discontinued, guideline-directed medical therapy was initiated, and an extravascular implantable cardioverter-defibrillator was placed for secondary prevention.
Discussion:
This case highlights a rare, severe presentation of fluoropyrimidine cardiotoxicity after the first treatment cycle despite no prior cardiac history.
Take-Home Message:
Ventricular fibrillation may occur early during FOLFOX therapy. Prompt recognition and multidisciplinary cardio-oncology management are essential.
Related Concept Videos
Diverticular Disease of the Colon
Dysrhythmias III: Characteristics of Dysrhythmias
Clot Retraction and Fibrinolysis
Drugs for Treatment of Ulcerative Colitis in IBD
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
